Jan. 11, 2021 – When considering all of the COVID-19 challenges the FDA faced in 2020, it is noteworthy that the Center for Drug Evaluation and Research (CDER) approved 53 novel drugs last year, the second highest number of novel drug approvals in the past 10 years. In a forward to CDER’s 2020 report on […]
Read more
July 20, 2020 – The Trump administration instructed hospital systems and providers last week that they should no longer report data on COVID-19 cases, hospitalizations, deaths, positive test results, etc. to the Centers for Disease Control and Prevention’s (CDC’s) National Healthcare Safety Network site, and instead should send this information to a newly launched data […]
Read more
June 15, 2020 – The COVID-19 pandemic has brought increased use of telemedicine and group conferencing platforms, as well as prompted talk of using cellphones to do contact tracing, but this uptick in using technology in new and expanded ways also has increased the risks to personal data. Unfortunately, at a time when consumer data […]
Read more